90 related articles for article (PubMed ID: 22833393)
1. Hypothesis-free analysis of ATG16L1 demonstrates gene-wide extent of association with Crohn's disease susceptibility.
Van Limbergen J; Kabakchiev B; Stempak JM; Schumm P; Xu W; Henderson P; Girardin S; Griffiths AM; Philpott D; Silverberg M
Gut; 2013 Feb; 62(2):331-3. PubMed ID: 22833393
[No Abstract] [Full Text] [Related]
2. Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2.
Plantinga TS; Crisan TO; Oosting M; van de Veerdonk FL; de Jong DJ; Philpott DJ; van der Meer JW; Girardin SE; Joosten LA; Netea MG
Gut; 2011 Sep; 60(9):1229-35. PubMed ID: 21406388
[TBL] [Abstract][Full Text] [Related]
3. The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner.
Sorbara MT; Ellison LK; Ramjeet M; Travassos LH; Jones NL; Girardin SE; Philpott DJ
Immunity; 2013 Nov; 39(5):858-73. PubMed ID: 24238340
[TBL] [Abstract][Full Text] [Related]
4. Crohn's disease susceptibility gene interactions, a NOD to the newcomer ATG16L1.
Cadwell K
Gastroenterology; 2010 Nov; 139(5):1448-50. PubMed ID: 20875485
[No Abstract] [Full Text] [Related]
5. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
[TBL] [Abstract][Full Text] [Related]
6. Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease.
Baldassano RN; Bradfield JP; Monos DS; Kim CE; Glessner JT; Casalunovo T; Frackelton EC; Otieno FG; Kanterakis S; Shaner JL; Smith RM; Eckert AW; Robinson LJ; Onyiah CC; Abrams DJ; Chiavacci RM; Skraban R; Devoto M; Grant SF; Hakonarson H
Gut; 2007 Aug; 56(8):1171-3. PubMed ID: 17625155
[No Abstract] [Full Text] [Related]
7. Bacterial invasion: linking autophagy and innate immunity.
Galluzzi L; Kepp O; Zitvogel L; Kroemer G
Curr Biol; 2010 Feb; 20(3):R106-8. PubMed ID: 20144769
[TBL] [Abstract][Full Text] [Related]
8. Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn's disease.
Hruz P; Eckmann L
Swiss Med Wkly; 2010; 140():w13135. PubMed ID: 21213148
[TBL] [Abstract][Full Text] [Related]
9. Autophagy genes variants and paediatric Crohn's disease phenotype: a single-centre experience.
Strisciuglio C; Auricchio R; Martinelli M; Staiano A; Giugliano FP; Andreozzi M; De Rosa M; Giannetti E; Gianfrani C; Izzo P; Troncone R; Miele E
Dig Liver Dis; 2014 Jun; 46(6):512-7. PubMed ID: 24656308
[TBL] [Abstract][Full Text] [Related]
10. [Role of NOD2 gene in Crohn's disease].
Hugot JP
Gastroenterol Clin Biol; 2002 Jan; 26(1):13-5. PubMed ID: 11938034
[No Abstract] [Full Text] [Related]
11. [Crohn's disease: a disease of innate immunity].
Peuchmaur M
Ann Pathol; 2003 Nov; Spec No 1():S40-9. PubMed ID: 14997616
[No Abstract] [Full Text] [Related]
12. IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes.
Lauriola M; Ugolini G; Rivetti S; Nanì S; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Belluzzi A; Castellani L; D'Uva G; Mattei G; Taffurelli M; Strippoli P; Solmi R
Int J Mol Med; 2011 Mar; 27(3):469-77. PubMed ID: 21206965
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.
Gutiérrez A; Scharl M; Sempere L; Holler E; Zapater P; Almenta I; González-Navajas JM; Such J; Wiest R; Rogler G; Francés R
Gut; 2014 Feb; 63(2):272-80. PubMed ID: 23376290
[TBL] [Abstract][Full Text] [Related]
14. [Barrier- and autophagic functions of the intestinal epithelia: role of disturbances in the pathogenesis of Crohn's disease].
Lapis K
Orv Hetil; 2010 Oct; 151(40):1645-55. PubMed ID: 20860961
[TBL] [Abstract][Full Text] [Related]
15. [NOD2: A functional and positional candidate gene in Crohn's disease].
Folwaczny C; Glas J
Z Gastroenterol; 2002 Mar; 40(3):205-7. PubMed ID: 11901457
[No Abstract] [Full Text] [Related]
16. The Crohn's associated NOD2 3020InsC frameshift mutation does not confer susceptibility to ankylosing spondylitis.
D'Amato M; Sorrentino R; Pettersson S
J Rheumatol; 2002 Nov; 29(11):2470-1. PubMed ID: 12415614
[No Abstract] [Full Text] [Related]
17. NOD2 insertion mutation in a Cretan Crohn's disease population.
Roussomoustakaki M; Koutroubakis I; Vardas EM; Dimoulios P; Kouroumalis EA; Baritaki S; Koutsoudakis G; Krambovitis E
Gastroenterology; 2003 Jan; 124(1):272-3; author reply 273-4. PubMed ID: 12512064
[No Abstract] [Full Text] [Related]
18. Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe.
Van Limbergen J; Russell RK; Nimmo ER; Drummond HE; Smith L; Anderson NH; Davies G; Gillett PM; McGrogan P; Weaver LT; Bisset WM; Mahdi G; Arnott ID; Wilson DC; Satsangi J
Inflamm Bowel Dis; 2008 Mar; 14(3):338-46. PubMed ID: 18088053
[TBL] [Abstract][Full Text] [Related]
19. Decoding norovirus infection in Crohn's disease.
Chamaillard M; Cesaro A; Lober PE; Hober D
Inflamm Bowel Dis; 2014 Apr; 20(4):767-70. PubMed ID: 24351661
[TBL] [Abstract][Full Text] [Related]
20. Overview: Nod2, cause of, or contributor to, Crohn's disease.
Punchard NA
Curr Opin Investig Drugs; 2001 Oct; 2(10):1378-81. PubMed ID: 11890351
[No Abstract] [Full Text] [Related]
[Next] [New Search]
